PharVision Advisers’s Netflix NFLX Stock Holding History

PharVision Advisers’s Portfolio NFLX Stock Details NFLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,663	Closed	-$250K	–	458
2025 Q4	$250K	Sell	2,663 -697	-21%	-$75.1K	0.13%	389
2025 Q3	$403K	Buy	+3,360	New	+$410K	0.23%	81
2025 Q1	–	Sell	-9,790	Closed	-$873K	–	440
2024 Q4	$873K	Buy	+9,790	New	+$806K	0.74%	5

Other funds holding NFLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PharVision Advisers's NFLX Position: Q1 2026 in Review

PharVision Advisers sold out of Netflix (NFLX) in Q1 2026, closing a stake of 2,663 shares — an estimated $250K sold.

PharVision Advisers first reported a position in NFLX in Q4 2024 and held it in 3 quarters. The position peaked at $873K in Q4 2024. 3,607 funds tracked by Wall St. Rank hold NFLX as of Q1 2026.

PharVision Advisers reported no remaining Netflix position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,663 Netflix shares in Q1 2026, an estimated $250K.
PharVision Advisers first reported a position in Netflix in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Netflix position peaked at $873K in Q4 2024.
3,607 funds tracked by Wall St. Rank held Netflix as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.